Sept 19 (Reuters) - Egetis Therapeutics AB (publ)
EGTX.ST :
* EGETIS SUBMITS A PATENT APPLICATION TO THE UNITED STATES
PATENT
AND TRADEMARK OFFICE FOR “PROCESSES OF PREPARATION” OF
TIRATRICOL
* IF GRANTED, THIS WOULD BE A SIGNIFICANT PATENT EGETIS HAS
OBTAINED FOR INVESTIGATIONAL DRUG TIRATRICOL
* GENERALLY, EXCLUSIVITY TERM OF A NEW PATENT IS 20 YEARS
FROM
DATE ON WHICH APPLICATION FOR PATENT WAS FILED IN UNITED STATES
Source text for Eikon: ID:nMFN7kC8rR
Further company coverage: EGTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))